New drugs for BNCT: an experimental approach
- PMID: 10394418
- DOI: 10.1007/BF03038909
New drugs for BNCT: an experimental approach
Abstract
New kinds of boron-containing drugs were developed and tested in several murine tumor models. The boron-containing ether lipid B-Et-11-OMe was injected in mammary carcinoma (AT17) and osteosarcoma (OTS-64) bearing mice. Furthermore boron-substituted ferrocenium derivatives were tested. Two were excessively toxic; the third could be investigated. Boron accumulation and time-dependent biodistribution were determined using alpha-particle sensitive films and inductively coupled plasma-atomic emission pectrometry (ICP-AES) and -mass spectrometry (ICP-MS) of tumors, organs and tissues. Additionally, a new method of boron detection by NMR is in preparation.
Similar articles
-
Uptake and distribution of the boron-containing ether lipid B-Et-11-OMe in tumor-bearing mice.Anticancer Drugs. 1995 Dec;6(6):744-8. doi: 10.1097/00001813-199512000-00005. Anticancer Drugs. 1995. PMID: 8845486
-
Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6512-7. doi: 10.1073/pnas.1303437110. Epub 2013 Mar 27. Proc Natl Acad Sci U S A. 2013. PMID: 23536304 Free PMC article.
-
New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.Anticancer Drugs. 1994 Feb;5(1):43-52. Anticancer Drugs. 1994. PMID: 8186429
-
The formulation of polyhedral boranes for the boron neutron capture therapy of cancer.Drug Discov Today. 2012 Feb;17(3-4):153-9. doi: 10.1016/j.drudis.2011.09.014. Epub 2011 Sep 29. Drug Discov Today. 2012. PMID: 21978988 Review.
-
Polyhedral boron compounds as potential diagnostic and therapeutic antitumor agents.Anticancer Agents Med Chem. 2006 Mar;6(2):75-109. doi: 10.2174/187152006776119180. Anticancer Agents Med Chem. 2006. PMID: 16529534 Review.